3.45
price up icon0.58%   0.02
after-market Handel nachbörslich: 3.45
loading

Polypid Ltd Aktie (PYPD) Neueste Nachrichten

pulisher
09:11 AM

Is PolyPid Ltd. forming a breakout patternDay Trade & Consistent Growth Stock Picks - thegnnews.com

09:11 AM
pulisher
08:09 AM

Detecting price anomalies in PolyPid Ltd. with AIJuly 2025 WrapUp & Weekly Watchlist of Top Performers - Newser

08:09 AM
pulisher
08:07 AM

Is PolyPid Ltd. a candidate for recovery playJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser

08:07 AM
pulisher
05:56 AM

Does PolyPid Ltd. qualify in momentum factor screeningJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser

05:56 AM
pulisher
03:51 AM

Pattern recognition hints at PolyPid Ltd. upside2025 Big Picture & Reliable Intraday Trade Plans - Newser

03:51 AM
pulisher
Aug 14, 2025

PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

PolyPid Reports Positive Phase 3 Results and Strengthens Leadership - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

PolyPid Releases Mid-2025 Financial Update - The Globe and Mail

Aug 14, 2025
pulisher
Aug 14, 2025

Is PolyPid Ltd. affected by consumer sentimentJuly 2025 Chart Watch & Breakout Confirmation Trade Signals - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

PolyPid : Investor Presentation (3e767d) - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

PolyPid Ltd. (NASDAQ:PYPD) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 14, 2025
pulisher
Aug 14, 2025

Can PolyPid Ltd. navigate macro headwinds2025 Market Sentiment & Risk Controlled Daily Trade Plans - thegnnews.com

Aug 14, 2025
pulisher
Aug 14, 2025

Will PolyPid Ltd. benefit from macro trendsWeekly Stock Recap & Expert Verified Stock Movement Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Risk adjusted return profile for PolyPid Ltd. analyzedEarnings Performance Report & Free Community Supported Trade Ideas - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

PolyPid Reports Strong Phase 3 Results and Financial Update - TipRanks

Aug 14, 2025
pulisher
Aug 13, 2025

Why PolyPid Ltd. stock attracts strong analyst attentionPortfolio Performance Report & AI Forecast Swing Trade Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid Q2 2025 Earnings Call Transcript - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid's Q2 2025 Earnings Call: Key Contradictions on CMC Readiness, GLP-1 Program, and Partnership Dynamics - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Transcript : PolyPid Ltd., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener

Aug 13, 2025
pulisher
Aug 13, 2025

908 Devices Inc. shares rise 8.11% intraday after PolyPid reported positive Phase 3 SHIELD II Trial Results. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

How institutional ownership impacts PolyPid Ltd. stockDay Trade & Daily Profit Focused Screening - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Developing predictive dashboards with PolyPid Ltd. dataJuly 2025 Sector Moves & Verified Swing Trading Watchlists - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

PolyPid's Surgical Innovation Shows Major Infection Prevention Success, Expands into Obesity Drug Market - Stock Titan

Aug 13, 2025
pulisher
Aug 13, 2025

Live market analysis of PolyPid Ltd.July 2025 Price Swings & High Win Rate Trade Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Comparing PolyPid Ltd. in custom built stock radars2025 Trading Recap & Low Risk High Reward Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What’s the recovery path for long term holders of PolyPid Ltd. [July 2025 Trends]High Accuracy Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Applying sector rotation models to PolyPid Ltd.Fundamental + Technical Combined Watchlist - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid Ltd. Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer - Quiver Quantitative

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid appoints Dr. Tweezer-Zaks as chief medical officer By Investing.com - Investing.com South Africa

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer - GlobeNewswire

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid Strengthens Leadership: Board Director Takes CMO Role Following Breakthrough Phase 3 Results - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Combining machine learning predictions for PolyPid Ltd.Pre-Market Stock Movement Summary and Review - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid Ltd. stock volume spike explainedDeep Stock Performance and Volatility Analysis - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

PolyPid (PYPD) to Release Quarterly Earnings on Wednesday - Defense World

Aug 12, 2025
pulisher
Aug 12, 2025

What makes PolyPid Ltd. stock price move sharplyQuarterly Investment Outlook and Key Summary - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Sector ETF performance correlation with PolyPid Ltd.Long Term Stock Growth Plan Suggestions - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Custom watchlist performance reports with PolyPid Ltd.Swing Entry Risk Mitigation with Chart Analysis - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Running Global Clinical Trials? PolyPid Shares Operational And Regulatory Insights - Clinical Leader

Aug 11, 2025
pulisher
Aug 10, 2025

Sector ETF performance correlation with PolyPid Ltd. [Portfolio Value Summary]Weekly Watchlist of Top Performers - Newser

Aug 10, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):